Registered entities
Arcturus Therapeutics, Inc.
Reg. No. 461981974United States
ARCTURUS THERAPEUTICS LTD.
Reg. No. 1566049United States
ARCTURUS INC.
Reg. No. 474447158United States
Arcturus Therapeutics Holdings Inc.
Reg. No. 32-0595345United States
ARCTURUS
Reg. No. 40103349840Latvia
Innovation
65 patent families (37 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 5,293 times.
| Year | Filings |
|---|---|
| 2015 | 7 |
| 2016 | 9 |
| 2017 | 16 |
| 2018 | 21 |
| 2019 | 13 |
| 2020 | 23 |
| 2021 | 25 |
| 2022 | 24 |
| 2023 | 29 |
| 2024 | 27 |
| 2025 | 25 |
| 2026 | 11 |
Social engagement
Social engagement: 20K social following, 8 posts in the last 12 months — below the industry typical range.
Investor mix
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 33% |
| Accelerator & incubator | 1 | 33% |
| Other / undisclosed | 1 | 33% |
Recent activity
2 Jul 2026
Partnership
Thermo Fisher Scientific
24 Jun 2026
Event
39th National CF Education Conference
22 Jun 2026
Event
2026 National Urea Cycle Disorders Foundation Annual Family Conference